{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:29:32Z","timestamp":1773966572608,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,2]],"date-time":"2027-03-02T00:00:00Z","timestamp":1803945600000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011084","name":"Sigma Xia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI185854"],"award-info":[{"award-number":["AI185854"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI175232"],"award-info":[{"award-number":["AI175232"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.anai.2025.12.004","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:11:13Z","timestamp":1765037473000},"page":"356-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epithelial expression of allergic inflammatory type 2 genes in adults with modulator-refractory cystic fibrosis"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7052-0640","authenticated-orcid":false,"given":"Lindsay","family":"Somerville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Boone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Etter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne I.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Borish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.anai.2025.12.004_bib0001","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2025.12.004_bib0002","doi-asserted-by":"crossref","DOI":"10.1177\/17534666241297877","article-title":"Modulator-refractory cystic fibrosis: defining the scope and challenges of an emerging at-risk population","volume":"18","author":"Somerville","year":"2024","journal-title":"Ther Adv Respir Dis"},{"issue":"1","key":"10.1016\/j.anai.2025.12.004_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13223-023-00760-z","article-title":"Association between cystic fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization","volume":"19","author":"Albon","year":"2023","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.12.004_bib0004","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/03007995.2016.1277196","article-title":"Frequency and costs of pulmonary exacerbations in patients with cystic fibrosis in the United States","volume":"33","author":"Rubin","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"10.1016\/j.anai.2025.12.004_bib0005","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1111\/all.16198","article-title":"Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy","volume":"79","author":"Cook","year":"2024","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2025.12.004_bib0006","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13223-023-00822-2","article-title":"The impact of CFTR modulator triple therapy on type 2 inflammatory response in patients with cystic fibrosis","volume":"19","author":"Mehta","year":"2023","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.12.004_bib0007","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jama.2024.22684","article-title":"Transcriptomic profiles in nasal epithelium and asthma endotypes in youth","volume":"333","author":"Yue","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.anai.2025.12.004_bib0008","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ebiom.2017.03.033","article-title":"A comprehensive evaluation of nasal and bronchial cytokines and chemokines following experimental rhinovirus infection in allergic asthma: increased interferons (IFN-\u03b3 and IFN-\u03bb) and Type 2 inflammation (IL-5 and IL-13)","volume":"19","author":"Hansel","year":"2017","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.anai.2025.12.004_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168680","article-title":"Altered epithelial gene expression in peripheral airways of severe asthma","volume":"12","author":"Singhania","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.anai.2025.12.004_bib0010","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1164\/rccm.202211-2096OC","article-title":"Cystic fibrosis reprograms airway epithelial IL-33 release and licenses IL-33-dependent inflammation","volume":"207","author":"Cook","year":"2023","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625013729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625013729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:27:11Z","timestamp":1773959231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120625013729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1081120625013729"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2025.12.004","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epithelial expression of allergic inflammatory type 2 genes in adults with modulator-refractory cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2025.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}